ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 078,50
-0,52%
Dow Jones
42 801,72
0,52%
DAX
22 795,26
-0,89%
Brent Oil
70,30
0,82%
Bitcoin
83 171,38
-5,49%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioRestorative Therapies Inc (BRTX)

  7. BioRestorative Therapies Inc (BRTX) Actualités

BRTX

BioRestorative Therapies (BRTX)

BioRestorative Therapies Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BRTX
DateHeureSourceTitreSymboleSociété
28/02/202513h57Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
27/02/202515h45GlobeNewswire Inc.BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic PainNASDAQ:BRTXBioRestorative Therapies Inc
27/02/202502h15GlobeNewswire Inc.BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline UpdateNASDAQ:BRTXBioRestorative Therapies Inc
25/02/202514h00GlobeNewswire Inc.BioRestorative to Provide a Positive FDA Update on Clinical PipelineNASDAQ:BRTXBioRestorative Therapies Inc
20/02/202514h30GlobeNewswire Inc.BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
19/02/202522h43Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
19/02/202522h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
10/02/202514h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
10/02/202513h00GlobeNewswire Inc.BRTX-100 Front and Center at ORS 2025NASDAQ:BRTXBioRestorative Therapies Inc
05/12/202412h45GlobeNewswire Inc.BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
13/11/202413h00GlobeNewswire Inc.BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical DataNASDAQ:BRTXBioRestorative Therapies Inc
12/11/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BRTXBioRestorative Therapies Inc
12/11/202422h05GlobeNewswire Inc.BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:BRTXBioRestorative Therapies Inc
06/11/202422h37Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BRTXBioRestorative Therapies Inc
06/11/202422h25Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
06/11/202413h00GlobeNewswire Inc.BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research SymposiumNASDAQ:BRTXBioRestorative Therapies Inc
05/11/202413h10GlobeNewswire Inc.BioRestorative Therapies Receives Expanded Tissue License from New York State Department of HealthNASDAQ:BRTXBioRestorative Therapies Inc
31/10/202412h00GlobeNewswire Inc.BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
10/10/202413h00GlobeNewswire Inc.BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor EventsNASDAQ:BRTXBioRestorative Therapies Inc
03/10/202422h15GlobeNewswire Inc.BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
19/09/202412h55GlobeNewswire Inc.BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 DrugsNASDAQ:BRTXBioRestorative Therapies Inc
13/08/202422h05GlobeNewswire Inc.BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:BRTXBioRestorative Therapies Inc
08/08/202422h23Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BRTXBioRestorative Therapies Inc
06/08/202422h05GlobeNewswire Inc.BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024NASDAQ:BRTXBioRestorative Therapies Inc
23/07/202413h10GlobeNewswire Inc.BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational MedicineNASDAQ:BRTXBioRestorative Therapies Inc
27/06/202413h40GlobeNewswire Inc.BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
17/06/202413h05GlobeNewswire Inc.BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial ResultsNASDAQ:BRTXBioRestorative Therapies Inc
13/06/202417h40AllPennyStocks.comShares of Biotech MicroCap Rip on Licensing TalksNASDAQ:BRTXBioRestorative Therapies Inc
13/06/202413h00GlobeNewswire Inc.BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
04/06/202414h50GlobeNewswire Inc.BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare ConferenceNASDAQ:BRTXBioRestorative Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:BRTX

Dernières Valeurs Consultées

BOV
SOJA3M
Boa Safra Sementes ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces